Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.35 | 5e-15 |
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-14 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.32 | 7e-14 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-13 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-12 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-12 |
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-14 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-14 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-13 |
mRNA | C18orf32 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-14 |